Covid-19 Impact on Infection Prevention and Enteral Access Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Infection Prevention and Enteral Access, including the following market information:
Major competitors identified in this market include Cook Medical, Medtronic plc, Boston Scientific Corporation, CONMED Corporation, CORPAK MedSystems, CR Bard, ALCOR Scientific, Pacific Hospital Supply, Teleflexorporated, Vygon SA, etc.
Based on the Region:
- Global Infection Prevention and Enteral Access Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
- Global Infection Prevention and Enteral Access Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
- Global Infection Prevention and Enteral Access Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
- Global Infection Prevention and Enteral Access Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)
Major competitors identified in this market include Cook Medical, Medtronic plc, Boston Scientific Corporation, CONMED Corporation, CORPAK MedSystems, CR Bard, ALCOR Scientific, Pacific Hospital Supply, Teleflexorporated, Vygon SA, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Enteral Feeding Pumps
- Enteral Feeding Tubes
- Administration Reservoirs
- Giving Sets
- Enteral Syringes
- Oncology
- Gastroenterology
- Diabetes
- Neurological Disorders
- Hypermetabolism
- Others
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Infection Prevention and Enteral Access Industry
1.7 COVID-19 Impact: Infection Prevention and Enteral Access Market Trends
2 GLOBAL INFECTION PREVENTION AND ENTERAL ACCESS QUARTERLY MARKET SIZE ANALYSIS
2.1 Infection Prevention and Enteral Access Business Impact Assessment - COVID-19
2.1.1 Global Infection Prevention and Enteral Access Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Infection Prevention and Enteral Access Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Infection Prevention and Enteral Access Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global Infection Prevention and Enteral Access Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Infection Prevention and Enteral Access Factory Price by Manufacturers
3.3 Location of Key Manufacturers Infection Prevention and Enteral Access Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Infection Prevention and Enteral Access Market
3.5 Key Manufacturers Infection Prevention and Enteral Access Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON INFECTION PREVENTION AND ENTERAL ACCESS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Enteral Feeding Pumps
1.4.2 Enteral Feeding Tubes
1.4.3 Administration Reservoirs
1.4.4 Giving Sets
1.4.5 Enteral Syringes
4.2 By Type, Global Infection Prevention and Enteral Access Market Size, 2019-2021
4.2.1 By Type, Global Infection Prevention and Enteral Access Market Size by Type, 2020-2021
4.2.2 By Type, Global Infection Prevention and Enteral Access Price, 2020-2021
5 IMPACT OF COVID-19 ON INFECTION PREVENTION AND ENTERAL ACCESS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Oncology
5.5.2 Gastroenterology
5.5.3 Diabetes
5.5.4 Neurological Disorders
5.5.5 Hypermetabolism
5.5.6 Others
5.2 By Application, Global Infection Prevention and Enteral Access Market Size, 2019-2021
5.2.1 By Application, Global Infection Prevention and Enteral Access Market Size by Application, 2019-2021
5.2.2 By Application, Global Infection Prevention and Enteral Access Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Cook Medical
7.1.1 Cook Medical Business Overview
7.1.2 Cook Medical Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
7.1.3 Cook Medical Infection Prevention and Enteral Access Product Introduction
7.1.4 Cook Medical Response to COVID-19 and Related Developments
7.2 Medtronic plc
7.2.1 Medtronic plc Business Overview
7.2.2 Medtronic plc Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
7.2.3 Medtronic plc Infection Prevention and Enteral Access Product Introduction
7.2.4 Medtronic plc Response to COVID-19 and Related Developments
7.3 Boston Scientific Corporation
7.3.1 Boston Scientific Corporation Business Overview
7.3.2 Boston Scientific Corporation Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
7.3.3 Boston Scientific Corporation Infection Prevention and Enteral Access Product Introduction
7.3.4 Boston Scientific Corporation Response to COVID-19 and Related Developments
7.4 CONMED Corporation
7.4.1 CONMED Corporation Business Overview
7.4.2 CONMED Corporation Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
7.4.3 CONMED Corporation Infection Prevention and Enteral Access Product Introduction
7.4.4 CONMED Corporation Response to COVID-19 and Related Developments
7.5 CORPAK MedSystems
7.5.1 CORPAK MedSystems Business Overview
7.5.2 CORPAK MedSystems Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
7.5.3 CORPAK MedSystems Infection Prevention and Enteral Access Product Introduction
7.5.4 CORPAK MedSystems Response to COVID-19 and Related Developments
7.6 CR Bard
7.6.1 CR Bard Business Overview
7.6.2 CR Bard Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
7.6.3 CR Bard Infection Prevention and Enteral Access Product Introduction
7.6.4 CR Bard Response to COVID-19 and Related Developments
7.7 ALCOR Scientific
7.7.1 ALCOR Scientific Business Overview
7.7.2 ALCOR Scientific Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
7.7.3 ALCOR Scientific Infection Prevention and Enteral Access Product Introduction
7.7.4 ALCOR Scientific Response to COVID-19 and Related Developments
7.8 Pacific Hospital Supply
7.8.1 Pacific Hospital Supply Business Overview
7.8.2 Pacific Hospital Supply Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
7.8.3 Pacific Hospital Supply Infection Prevention and Enteral Access Product Introduction
7.8.4 Pacific Hospital Supply Response to COVID-19 and Related Developments
7.9 Teleflexorporated
7.9.1 Teleflexorporated Business Overview
7.9.2 Teleflexorporated Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
7.9.3 Teleflexorporated Infection Prevention and Enteral Access Product Introduction
7.9.4 Teleflexorporated Response to COVID-19 and Related Developments
7.10 Vygon SA
7.10.1 Vygon SA Business Overview
7.10.2 Vygon SA Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
7.10.3 Vygon SA Infection Prevention and Enteral Access Product Introduction
7.10.4 Vygon SA Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Infection Prevention and Enteral Access Supply Chain Analysis
8.1.1 Infection Prevention and Enteral Access Supply Chain Analysis
8.1.2 Covid-19 Impact on Infection Prevention and Enteral Access Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Infection Prevention and Enteral Access Distribution Channels
8.2.2 Covid-19 Impact on Infection Prevention and Enteral Access Distribution Channels
8.2.3 Infection Prevention and Enteral Access Distributors
8.3 Infection Prevention and Enteral Access Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Infection Prevention and Enteral Access Industry
1.7 COVID-19 Impact: Infection Prevention and Enteral Access Market Trends
2 GLOBAL INFECTION PREVENTION AND ENTERAL ACCESS QUARTERLY MARKET SIZE ANALYSIS
2.1 Infection Prevention and Enteral Access Business Impact Assessment - COVID-19
2.1.1 Global Infection Prevention and Enteral Access Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Infection Prevention and Enteral Access Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Infection Prevention and Enteral Access Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 Global Infection Prevention and Enteral Access Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Infection Prevention and Enteral Access Factory Price by Manufacturers
3.3 Location of Key Manufacturers Infection Prevention and Enteral Access Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Infection Prevention and Enteral Access Market
3.5 Key Manufacturers Infection Prevention and Enteral Access Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON INFECTION PREVENTION AND ENTERAL ACCESS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Enteral Feeding Pumps
1.4.2 Enteral Feeding Tubes
1.4.3 Administration Reservoirs
1.4.4 Giving Sets
1.4.5 Enteral Syringes
4.2 By Type, Global Infection Prevention and Enteral Access Market Size, 2019-2021
4.2.1 By Type, Global Infection Prevention and Enteral Access Market Size by Type, 2020-2021
4.2.2 By Type, Global Infection Prevention and Enteral Access Price, 2020-2021
5 IMPACT OF COVID-19 ON INFECTION PREVENTION AND ENTERAL ACCESS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Oncology
5.5.2 Gastroenterology
5.5.3 Diabetes
5.5.4 Neurological Disorders
5.5.5 Hypermetabolism
5.5.6 Others
5.2 By Application, Global Infection Prevention and Enteral Access Market Size, 2019-2021
5.2.1 By Application, Global Infection Prevention and Enteral Access Market Size by Application, 2019-2021
5.2.2 By Application, Global Infection Prevention and Enteral Access Price, 2020-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 Cook Medical
7.1.1 Cook Medical Business Overview
7.1.2 Cook Medical Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
7.1.3 Cook Medical Infection Prevention and Enteral Access Product Introduction
7.1.4 Cook Medical Response to COVID-19 and Related Developments
7.2 Medtronic plc
7.2.1 Medtronic plc Business Overview
7.2.2 Medtronic plc Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
7.2.3 Medtronic plc Infection Prevention and Enteral Access Product Introduction
7.2.4 Medtronic plc Response to COVID-19 and Related Developments
7.3 Boston Scientific Corporation
7.3.1 Boston Scientific Corporation Business Overview
7.3.2 Boston Scientific Corporation Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
7.3.3 Boston Scientific Corporation Infection Prevention and Enteral Access Product Introduction
7.3.4 Boston Scientific Corporation Response to COVID-19 and Related Developments
7.4 CONMED Corporation
7.4.1 CONMED Corporation Business Overview
7.4.2 CONMED Corporation Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
7.4.3 CONMED Corporation Infection Prevention and Enteral Access Product Introduction
7.4.4 CONMED Corporation Response to COVID-19 and Related Developments
7.5 CORPAK MedSystems
7.5.1 CORPAK MedSystems Business Overview
7.5.2 CORPAK MedSystems Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
7.5.3 CORPAK MedSystems Infection Prevention and Enteral Access Product Introduction
7.5.4 CORPAK MedSystems Response to COVID-19 and Related Developments
7.6 CR Bard
7.6.1 CR Bard Business Overview
7.6.2 CR Bard Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
7.6.3 CR Bard Infection Prevention and Enteral Access Product Introduction
7.6.4 CR Bard Response to COVID-19 and Related Developments
7.7 ALCOR Scientific
7.7.1 ALCOR Scientific Business Overview
7.7.2 ALCOR Scientific Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
7.7.3 ALCOR Scientific Infection Prevention and Enteral Access Product Introduction
7.7.4 ALCOR Scientific Response to COVID-19 and Related Developments
7.8 Pacific Hospital Supply
7.8.1 Pacific Hospital Supply Business Overview
7.8.2 Pacific Hospital Supply Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
7.8.3 Pacific Hospital Supply Infection Prevention and Enteral Access Product Introduction
7.8.4 Pacific Hospital Supply Response to COVID-19 and Related Developments
7.9 Teleflexorporated
7.9.1 Teleflexorporated Business Overview
7.9.2 Teleflexorporated Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
7.9.3 Teleflexorporated Infection Prevention and Enteral Access Product Introduction
7.9.4 Teleflexorporated Response to COVID-19 and Related Developments
7.10 Vygon SA
7.10.1 Vygon SA Business Overview
7.10.2 Vygon SA Infection Prevention and Enteral Access Quarterly Production and Revenue, 2020
7.10.3 Vygon SA Infection Prevention and Enteral Access Product Introduction
7.10.4 Vygon SA Response to COVID-19 and Related Developments
8 SUPPLY CHAIN AND SALES CHANNELS ANALYSIS
8.1 Infection Prevention and Enteral Access Supply Chain Analysis
8.1.1 Infection Prevention and Enteral Access Supply Chain Analysis
8.1.2 Covid-19 Impact on Infection Prevention and Enteral Access Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Infection Prevention and Enteral Access Distribution Channels
8.2.2 Covid-19 Impact on Infection Prevention and Enteral Access Distribution Channels
8.2.3 Infection Prevention and Enteral Access Distributors
8.3 Infection Prevention and Enteral Access Customers
9 KEY FINDINGS
10 APPENDIX
10.1 About Us
10.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Infection Prevention and Enteral Access Assessment
Table 9. COVID-19 Impact: Infection Prevention and Enteral Access Market Trends
Table 10. COVID-19 Impact Global Infection Prevention and Enteral Access Market Size
Table 11. Global Infection Prevention and Enteral Access Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Infection Prevention and Enteral Access Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Infection Prevention and Enteral Access Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Infection Prevention and Enteral Access Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Infection Prevention and Enteral Access Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Infection Prevention and Enteral Access Market Growth Drivers
Table 17. Global Infection Prevention and Enteral Access Market Restraints
Table 18. Global Infection Prevention and Enteral Access Market Opportunities
Table 19. Global Infection Prevention and Enteral Access Market Challenges
Table 20. Key Manufacturers Infection Prevention and Enteral Access Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Infection Prevention and Enteral Access Market Size, 2019 (K Units) & (US$ Million)
Table 22. Infection Prevention and Enteral Access Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Infection Prevention and Enteral Access Manufacturing Plants
Table 24. Key Manufacturers Infection Prevention and Enteral Access Market Served
Table 25. Date of Key Manufacturers Enter into Infection Prevention and Enteral Access Market
Table 26. Key Manufacturers Infection Prevention and Enteral Access Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Infection Prevention and Enteral Access Market Size by Type, 2020, (US$ Million)
Table 29. Global Infection Prevention and Enteral Access Market Size by Type, 2020 (K Units)
Table 30. Global Infection Prevention and Enteral Access Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Infection Prevention and Enteral Access Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Infection Prevention and Enteral Access Market Size by Application, 2020-2021 (K Units)
Table 33. Global Infection Prevention and Enteral Access Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Infection Prevention and Enteral Access Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Infection Prevention and Enteral Access Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Infection Prevention and Enteral Access Market Size, 2019-2021 (K Units)
Table 38. US Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Infection Prevention and Enteral Access Market Size, 2019-2021 (K Units)
Table 43. Germany Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Infection Prevention and Enteral Access Market Size, 2019-2021 (K Units)
Table 50. China Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Cook Medical Business Overview
Table 58. Cook Medical Infection Prevention and Enteral Access Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Cook Medical Infection Prevention and Enteral Access Product
Table 60. Cook Medical Response to COVID-19 and Related Developments
Table 61. Medtronic plc Business Overview
Table 62. Medtronic plc Infection Prevention and Enteral Access Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Medtronic plc Infection Prevention and Enteral Access Product
Table 64. Medtronic plc Response to COVID-19 and Related Developments
Table 65. Boston Scientific Corporation Business Overview
Table 66. Boston Scientific Corporation Infection Prevention and Enteral Access Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Boston Scientific Corporation Infection Prevention and Enteral Access Product
Table 68. Boston Scientific Corporation Response to COVID-19 and Related Developments
Table 69. CONMED Corporation Business Overview
Table 70. CONMED Corporation Infection Prevention and Enteral Access Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. CONMED Corporation Infection Prevention and Enteral Access Product
Table 72. CONMED Corporation Response to COVID-19 and Related Developments
Table 73. CORPAK MedSystems Business Overview
Table 74. CORPAK MedSystems Infection Prevention and Enteral Access Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. CORPAK MedSystems Infection Prevention and Enteral Access Product
Table 76. CORPAK MedSystems Response to COVID-19 and Related Developments
Table 77. CR Bard Business Overview
Table 78. CR Bard Infection Prevention and Enteral Access Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. CR Bard Infection Prevention and Enteral Access Product
Table 80. CR Bard Response to COVID-19 and Related Developments
Table 81. ALCOR Scientific Business Overview
Table 82. ALCOR Scientific Infection Prevention and Enteral Access Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. ALCOR Scientific Infection Prevention and Enteral Access Product
Table 84. ALCOR Scientific Response to COVID-19 and Related Developments
Table 85. Pacific Hospital Supply Business Overview
Table 86. Pacific Hospital Supply Infection Prevention and Enteral Access Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Pacific Hospital Supply Infection Prevention and Enteral Access Product
Table 88. Pacific Hospital Supply Response to COVID-19 and Related Developments
Table 89. Teleflexorporated Business Overview
Table 90. Teleflexorporated Infection Prevention and Enteral Access Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Teleflexorporated Infection Prevention and Enteral Access Product
Table 92. Teleflexorporated Response to COVID-19 and Related Developments
Table 93. Vygon SA Business Overview
Table 94. Vygon SA Infection Prevention and Enteral Access Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Vygon SA Infection Prevention and Enteral Access Product
Table 96. Vygon SA Response to COVID-19 and Related Developments
Table 97. Infection Prevention and Enteral Access Distributors List
Table 98. Infection Prevention and Enteral Access Customers List
Table 99. Covid-19 Impact on Infection Prevention and Enteral Access Customers
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Infection Prevention and Enteral Access Assessment
Table 9. COVID-19 Impact: Infection Prevention and Enteral Access Market Trends
Table 10. COVID-19 Impact Global Infection Prevention and Enteral Access Market Size
Table 11. Global Infection Prevention and Enteral Access Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Infection Prevention and Enteral Access Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Infection Prevention and Enteral Access Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Infection Prevention and Enteral Access Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Infection Prevention and Enteral Access Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Infection Prevention and Enteral Access Market Growth Drivers
Table 17. Global Infection Prevention and Enteral Access Market Restraints
Table 18. Global Infection Prevention and Enteral Access Market Opportunities
Table 19. Global Infection Prevention and Enteral Access Market Challenges
Table 20. Key Manufacturers Infection Prevention and Enteral Access Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Infection Prevention and Enteral Access Market Size, 2019 (K Units) & (US$ Million)
Table 22. Infection Prevention and Enteral Access Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Infection Prevention and Enteral Access Manufacturing Plants
Table 24. Key Manufacturers Infection Prevention and Enteral Access Market Served
Table 25. Date of Key Manufacturers Enter into Infection Prevention and Enteral Access Market
Table 26. Key Manufacturers Infection Prevention and Enteral Access Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Infection Prevention and Enteral Access Market Size by Type, 2020, (US$ Million)
Table 29. Global Infection Prevention and Enteral Access Market Size by Type, 2020 (K Units)
Table 30. Global Infection Prevention and Enteral Access Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Infection Prevention and Enteral Access Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Infection Prevention and Enteral Access Market Size by Application, 2020-2021 (K Units)
Table 33. Global Infection Prevention and Enteral Access Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Infection Prevention and Enteral Access Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Infection Prevention and Enteral Access Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Infection Prevention and Enteral Access Market Size, 2019-2021 (K Units)
Table 38. US Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Infection Prevention and Enteral Access Market Size, 2019-2021 (K Units)
Table 43. Germany Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Infection Prevention and Enteral Access Market Size, 2019-2021 (K Units)
Table 50. China Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Infection Prevention and Enteral Access Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Cook Medical Business Overview
Table 58. Cook Medical Infection Prevention and Enteral Access Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Cook Medical Infection Prevention and Enteral Access Product
Table 60. Cook Medical Response to COVID-19 and Related Developments
Table 61. Medtronic plc Business Overview
Table 62. Medtronic plc Infection Prevention and Enteral Access Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Medtronic plc Infection Prevention and Enteral Access Product
Table 64. Medtronic plc Response to COVID-19 and Related Developments
Table 65. Boston Scientific Corporation Business Overview
Table 66. Boston Scientific Corporation Infection Prevention and Enteral Access Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Boston Scientific Corporation Infection Prevention and Enteral Access Product
Table 68. Boston Scientific Corporation Response to COVID-19 and Related Developments
Table 69. CONMED Corporation Business Overview
Table 70. CONMED Corporation Infection Prevention and Enteral Access Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. CONMED Corporation Infection Prevention and Enteral Access Product
Table 72. CONMED Corporation Response to COVID-19 and Related Developments
Table 73. CORPAK MedSystems Business Overview
Table 74. CORPAK MedSystems Infection Prevention and Enteral Access Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. CORPAK MedSystems Infection Prevention and Enteral Access Product
Table 76. CORPAK MedSystems Response to COVID-19 and Related Developments
Table 77. CR Bard Business Overview
Table 78. CR Bard Infection Prevention and Enteral Access Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. CR Bard Infection Prevention and Enteral Access Product
Table 80. CR Bard Response to COVID-19 and Related Developments
Table 81. ALCOR Scientific Business Overview
Table 82. ALCOR Scientific Infection Prevention and Enteral Access Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. ALCOR Scientific Infection Prevention and Enteral Access Product
Table 84. ALCOR Scientific Response to COVID-19 and Related Developments
Table 85. Pacific Hospital Supply Business Overview
Table 86. Pacific Hospital Supply Infection Prevention and Enteral Access Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Pacific Hospital Supply Infection Prevention and Enteral Access Product
Table 88. Pacific Hospital Supply Response to COVID-19 and Related Developments
Table 89. Teleflexorporated Business Overview
Table 90. Teleflexorporated Infection Prevention and Enteral Access Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Teleflexorporated Infection Prevention and Enteral Access Product
Table 92. Teleflexorporated Response to COVID-19 and Related Developments
Table 93. Vygon SA Business Overview
Table 94. Vygon SA Infection Prevention and Enteral Access Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Vygon SA Infection Prevention and Enteral Access Product
Table 96. Vygon SA Response to COVID-19 and Related Developments
Table 97. Infection Prevention and Enteral Access Distributors List
Table 98. Infection Prevention and Enteral Access Customers List
Table 99. Covid-19 Impact on Infection Prevention and Enteral Access Customers
LIST OF FIGURES
Figure 1. Infection Prevention and Enteral Access Product Picture
Figure 2. Infection Prevention and Enteral Access Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Infection Prevention and Enteral Access Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Infection Prevention and Enteral Access Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Infection Prevention and Enteral Access Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Infection Prevention and Enteral Access Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Infection Prevention and Enteral Access Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Infection Prevention and Enteral Access Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Infection Prevention and Enteral Access Market Size Market Share, 2019-2021
Figure 1. Infection Prevention and Enteral Access Product Picture
Figure 2. Infection Prevention and Enteral Access Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Infection Prevention and Enteral Access Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Infection Prevention and Enteral Access Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Infection Prevention and Enteral Access Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Infection Prevention and Enteral Access Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Infection Prevention and Enteral Access Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Infection Prevention and Enteral Access Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Infection Prevention and Enteral Access Market Size Market Share, 2019-2021
